| GTO ID | GTC1593 |
| Trial ID | NCT02706782 |
| Disease | Pancreatic Cancer |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MESO CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma |
| Year | 2016 |
| Country | China |
| Company sponsor | Shanghai GeneChem Co., Ltd. |
| Other ID(s) | Genechem meso-CART |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||||
|
|||||||||||